Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06904495

Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age

Medical professionals now take into account the specificities of the care and support of Adolescents and Young Adults (AYAs). Cancer aftermaths in patients diagnosed during the AYA period are also known: the consequences of chemotherapy and radiotherapy treatments on a growing organism, the difficulty of some follow-ups, the longevity, and the delayed occurrence of certain complications.

In the general population, sleep disorders affect 40% of adolescents. About 30% of pediatric cancer survivors experience fatigue they attribute to their cancer, even years after the end of their treatment. The sleep quality of patients treated for cancer when they were AYAs, and the eventual care of sleeping disorders, are poorly studied. The investigators suppose that the oncologic treatment during this particular life stage, when sleeping disorders are already present and multifactorial, could have long-term impacts on sleep. The investigators offer to evaluate, through a questionnaire filled out by patients treated for cancer in the AYA period, the frequency of moderate to severe insomnia.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

15 year–24 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de Nice

Nice, France

Location status: Recruiting

Location contact

Méryl Horwitz, Dr

CONTACT

[email protected]

492036795 ext. +33

Méryl Horwitz, Dr

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient treated for a cancer
  • Patient aged between 15 and 24 years old at the time of the diagnosis
  • Patients whom intensive treatment ended at least 3 months ago
  • Patient followed in a PACAAURA cancerology center
  • Life expectancy ≥ 6 months
  • Karnosky index > 60%
  • Patient who agrees to participate in the program and benefits from social security
  • Patient able to understand, speak and read French.
  • No major cognitive impairment (assessed by the patient's referees)
  • No sensory disability

Exclusion criteria

  • Patient unable to use informatic tools
  • Known superior cognitive function disorders
  • Progressive psychiatric pathology
  • Drug user or alcohol abuse

Treatment and study plan

Survey of sleep quality and associated factors

Other

Sleep quality and associated factors (anxiety, depression, and pain) will be evaluated through an online survey on the Reseau Morphee platform, through an self-administered evaluation of the patients' pain and sleep difficulties, and a precarity scale.

Primary outcomes

  1. Number of patients presenting moderate or severe insomnia

    Time frame: Day 1

    Online self-administered questionnaire filled-out by the patient (120 questions) Scores between 1 and 10, yes or no, multiple choice questions, open-ended questions

Secondary outcomes

  1. Identification of sleep disorders risk factors

    Time frame: Day 1

    Self-administered questionnaire filled-out by the patient (120 questions) self-administered evaluation of the patients' pain and sleep difficulties Precarity scale Scores between 1 and 10, yes or no, multiple choice questions, open-ended questions

Study contacts

Contact information is provided by the study sponsor or research team.

Meryl Horwitz, Dr

CONTACT

[email protected]

492036795 ext. +33

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Acronym: SOM'AJA

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 1, 2025
Registry last updated
Feb 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.